EBITDA (Quarterly)

EBITDA: Income before interest, taxes, depreciation and amortization.

Immunocore Holdings PLC Sponsored ADR (IMCR) had EBITDA of $8.23M for the most recently reported fiscal quarter, ending 2026-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2026-03-31

Income Statement Financials
Revenue	$106.68M
Net Income	$12.97M
Cost of Goods Sold	$0.43M
Gross Profit	$106.24M
Operating Expenses	$99.40M
Operating Income	$7.28M
Non-Operating Income/Expense	$5.99M
Pre-Tax Income	$13.27M
Normalized Pre-Tax Income	$13.27M
Income after Taxes	$12.97M
Income from Continuous Operations	$12.97M
Consolidated Net Income/Loss	$12.97M
Normalized Income after Taxes	$12.97M
EBIT	$7.28M
EBITDA	$8.23M
Weighted-Average Shares Outstanding (Basic)	50.76M
Weighted-Average Shares Outstanding (Diluted)	52.94M
Earnings per Share (EPS) (Basic)	$0.26
Earnings per Share (EPS) (Diluted)	$0.25
Balance Sheet Financials
Current Assets	$1.00B
Property, Plant, and Equipment	$12.13M
Long-Term Assets	$68.29M
Total Assets	$1.07B
Current Liabilities	$240.11M
Long-Term Debt	$393.66M
Long-Term Liabilities	$438.31M
Total Liabilities	$678.42M
Common Equity	$393.67M
Tangible Shareholders Equity	$393.67M
Shareholders Equity	$393.67M
Common Shares Outstanding	50.83M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-13.78M
Cash Flow from Investing Activities	$4.22M
Cash Flow from Financial Activities	$0.66M
Beginning Cash	$467.71M
End Cash	$452.68M
Increase/Decrease in Cash	$-15.03M
Stock-Based Compensation	$6.30M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	4.18
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.50
Debt to Equity Ratio	1.00
Gross Margin	99.59%
Operating Margin	6.82%
EBIT Margin	6.82%
EBITDA Margin	--
Pre-Tax Profit Margin	12.44%
Profit Margin	12.16%
Free Cash Flow	$-15.56M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.10
Inventory Turnover	0.05
Receiveable Turnover	1.32
Days Sales in Receivables	68.39
Return on Equity	3.29%
Return on Tangible Equity	3.29%
Return on Assets	1.21%
Return on Investments	1.65%
Book Value Per Share	$7.74
Free Cash Flow per Share	$-0.29
Operating Cash Flow per Share	$-0.26

Data from Zacks Investment Research, Inc.